Neurosurgical Clinical Trial Unit - STICH II

Newcastle Neurosurgery Clinical Trials Unit	Neurosurgical Clinical Trial Unit

Neurosurgical Clinical Trial Unit - STICH II

.

click on the logo to go to the relevant external trial webpage	STICH II
	International multi-centre trial is to evaluate the role of early surgery in superficial supratentorial lobar haematomas without intraventricular haemorrhage. STICH II is a multi-centre randomised parallel group trial comparing early craniotomy to evacuate the haematoma with initial conservative treatment, following spontaneous superficial intracerebral haemorrhage.
	Brief inclusion / exclusion criteria
About STICH II Protocol Study Summary Contact Information Forms - Newcastle only Patient Information Sheet Relative Information Sheet Patient Consent Form Relative Assent Form	Inclusion: Spontaneous lobar ICH on CT Scan Patient randomised within 48 hours of ictus Surgeon is in equipoise Best MOTOR score on GCS of 5 or 6 and best EYE score on the GCS of 2 or more Volume of haematoma between 10 and 100ml [using Broderick Method (axbxc)/2] Exclusion: Aneurysm, tumour, trauma, angiographically proven AVM Intraventricular haemorrhage Hydrocephalus Brain stem / cerebellar haemorrhage Severe pre-existing physical or mental disability or severe co-morbidity Surgery cannot be performed within 12 hours Unreversed clotting or coagulation problems

Staff Involved	Principal Investigators:	Prof. A.D. Mendelow Dr. B. Gregson Mr. P. Mitchell Prof. G. Murray Dr. A. Gholkar	Assigned Registrar:	All

brains

Last updated 29 Jan 2008
© STICH